Literature DB >> 24332057

[Clinicopathological and survival features of primary hepatic lymphoma: an analysis of 35 cases].

Qian Zhao1, Hai-ping Liu1, Yi-jin Gu1, Wen-ming Cong2.   

Abstract

OBJECTIVE: To evaluate the clinicopathological features and prognosis of primary hepatic lymphoma (PHL).
METHODS: Thirty-five patients with PHL who underwent surgical resection and were confirmed by pathology in our hospital from 1982 to 2012 were re-evaluated for clinicopathological data, including their symptoms, radiological features, recurrence interval, histopathological properties and prognosis.
RESULTS: Of the 35 patients, 25 were men (71.4%) and 10 were women (28.6%), with an average age of 52.6 years old (range, 17-79 years). Presented symptoms were epigastric phymatosis, abdominal pain and low-grade fever. In the present study, 21 (60.0%) patients were positive for HBsAg, 1(2.9%) patient was positive for anti-HCV, 3 patients were positive for AFP, 12 patients and 2 patients were complicated by cirrhosis and hepatocellular carcinoma, respectively. Pathologically, 35 PHL were classified into 19 DLBCL (54.3%), 13 T cell-lymphoma (37.1%), and 3 MALT lymphoma (8.6%). Patients with DCBCL showed better postoperative survival than patients with T cell-lymphoma (31.7 ± 3.2) months vs. (22.9 ± 2.2) months (P < 0.05).
CONCLUSIONS: Hepatitis B virus (HBV) infection may contribute to the pathogenesis of Chinese patients with PHL. Surgical resection followed by comprehensive therapy is the first-line option for PHL. The prognosis of patients with PHL is associated with PHL subtypes.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24332057

Source DB:  PubMed          Journal:  Zhonghua Zhong Liu Za Zhi        ISSN: 0253-3766


  2 in total

1.  Primary hepatic non-Hodgkin's lymphoma with rectal cancer: A case report.

Authors:  Guo-Bin Wu; Chao-Yuan Huang; Shan Huang; Hai-Ming Ru; Bang-DE Xiang; Wei-Ping Yuan; Fei-Xiang Wu; Jian-Yong Liu; Zhi-Ming Zhang; Liang Ma; Zu-Shun Chen; Yin-Nong Zhao; LE-Qun Li
Journal:  Oncol Lett       Date:  2014-11-05       Impact factor: 2.967

2.  Incidence, Prognostic Factors and Survival Outcome in Patients With Primary Hepatic Lymphoma.

Authors:  Shi-Long Zhang; Chen Chen; Qian-Wen Rao; Zhe Guo; Xin Wang; Zhi-Ming Wang; Li-Shun Wang
Journal:  Front Oncol       Date:  2020-05-14       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.